Panacea Biotec
Panacea Biotec GmbH is delivers and markets products in transplantation, immunsuppression and anti-infection.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD890m—1.3b (Dealroom.co estimates Apr 2019.)
Lalru Punjab (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $144m | Late VC | |
N/A | $24.3m | Grant | |
$16.1m | Secondary | ||
* | $20.0m | Debt | |
Total Funding | AUD260m |
Related Content
Recent News about Panacea Biotec
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.